Arabian International Healthcare Holding Company

SASE:9530 Stock Report

Market Cap: ر.س791.6m

Arabian International Healthcare Holding Past Earnings Performance

Past criteria checks 3/6

Arabian International Healthcare Holding's earnings have been declining at an average annual rate of -32.7%, while the Healthcare industry saw earnings growing at 18.7% annually. Revenues have been declining at an average rate of 3.2% per year. Arabian International Healthcare Holding's return on equity is 11.8%, and it has net margins of 4.7%.

Key information

-32.7%

Earnings growth rate

-174.0%

EPS growth rate

Healthcare Industry Growth12.3%
Revenue growth rate-3.2%
Return on equity11.8%
Net Margin4.7%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

Returns On Capital Signal Tricky Times Ahead For Arabian International Healthcare Holding (TADAWUL:9530)

Jul 19
Returns On Capital Signal Tricky Times Ahead For Arabian International Healthcare Holding (TADAWUL:9530)

Here's What's Concerning About Arabian International Healthcare Holding's (TADAWUL:9530) Returns On Capital

Mar 22
Here's What's Concerning About Arabian International Healthcare Holding's (TADAWUL:9530) Returns On Capital

Calculating The Fair Value Of Arabian International Healthcare Holding Company (TADAWUL:9530)

Aug 30
Calculating The Fair Value Of Arabian International Healthcare Holding Company (TADAWUL:9530)

Revenue & Expenses Breakdown

How Arabian International Healthcare Holding makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SASE:9530 Revenue, expenses and earnings (SAR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 23807381430
30 Sep 23775281310
30 Jun 23743241170
31 Mar 23693251130
31 Dec 22643201100
30 Sep 2261439960
30 Jun 2258557830
31 Mar 2260269780
31 Dec 2161982730
30 Sep 21746107860
30 Jun 21874132980
31 Mar 21846114990
31 Dec 20819961000
31 Dec 19697411100

Quality Earnings: 9530 has a large one-off gain of SAR28.1M impacting its last 12 months of financial results to 31st December, 2023.

Growing Profit Margin: 9530's current net profit margins (4.7%) are higher than last year (3.2%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 9530's earnings have declined by 32.7% per year over the past 5 years.

Accelerating Growth: 9530's earnings growth over the past year (86%) exceeds its 5-year average (-32.7% per year).

Earnings vs Industry: 9530 earnings growth over the past year (86%) exceeded the Healthcare industry 42.3%.


Return on Equity

High ROE: 9530's Return on Equity (11.8%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies